4.0 Article

QT intervals compared in small and large hibernators and humans

Journal

BIOLOGICAL RHYTHM RESEARCH
Volume 39, Issue 5, Pages 427-438

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/09291010701633545

Keywords

QT interval; EKG; cardiac electrophysiology; hibernation

Funding

  1. Office of Naval Research [N00014-75-C-0635]
  2. Department of Molecular Physiology and Biophysics
  3. Department of Emergency Medicine of the University of Iowa College of Medicine

Ask authors/readers for more resources

Small hibernating animals experience cycles of deep hypothermia followed by rewarming and feeding. This contrasts with bears, which remain in hibernation for four to seven months, experiencing large reductions in energy metabolism and heart rate, and small reductions in core temperature, and do not eat, drink, urinate, or defecate throughout. We measured the QT interval (QT) of the electrocardiogram (EKG) to determine whether the hearts of bears behave electrophysiologically more like classic hibernators or non-hibernators. We compared EKGs from grizzly and polar bears with small hibernators (marmots) and humans. Animal data were obtained using implanted radio capsules. EKGs of non-dormant marmots were characterized by a shortened QT (0.07-0.14 s); this held for grizzly and polar bears (0.14-0.23 s), but not for humans (0.39 s). Thus, the QT of bears resembles that of small hibernators. At the same heart rate, the QT of non-dormant bears and marmots differs in winter and summer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Public, Environmental & Occupational Health

Humanitarian Training With Virtual Simulation During a Pandemic

Sean M. Kivlehan, Kathryne Tenney, Sam Plasmati, Vincenzo Bollettino, Katie Farineau, Eric J. Nilles, Greg Gottlieb, Stephanie R. Kayden

Summary: There is a continuous need for humanitarian training and professionalization. The COVID-19 pandemic disrupted in-person training programs, but a virtual humanitarian training simulation proved to be a feasible alternative. The virtual format preserved learning objectives, received positive feedback from participants, and was more affordable than traditional simulations.

DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS (2022)

Article Multidisciplinary Sciences

Interactions between timing and transmissibility explain diverse flavivirus dynamics in Fiji

Alasdair D. Henderson, Mike Kama, Maite Aubry, Stephane Hue, Anita Teissier, Taina Naivalu, Vinaisi D. Bechu, Jimaima Kailawadoko, Isireli Rabukawaqa, Aalisha Sahukhan, Martin L. Hibberd, Eric J. Nilles, Sebastian Funk, Jimmy Whitworth, Conall H. Watson, Colleen L. Lau, W. John Edmunds, Van-Mai Cao-Lormeau, Adam J. Kucharski

Summary: After experiencing multiple dengue epidemics, Fiji showed evidence of multi-year Zika virus transmission between 2013 and 2017, likely influenced by seasonal effects and timing of introduction. This study highlights contrasting transmission dynamics of closely related flaviviruses in the same populations, emphasizing the importance of considering multiple factors in outbreak modeling.

NATURE COMMUNICATIONS (2021)

Article Medicine, General & Internal

Implications of a travel connectivity-based approach for infectious disease transmission risks in Oceania

Angela Cadavid Restrepo, Luis Furuya-Kanamori, Helen Mayfield, Eric Nilles, Colleen L. Lau

Summary: Globalization has led to increased international travel, facilitating the rapid spread of emerging pathogens with epidemic potential. This study analyzed travel data and the Infectious Disease Vulnerability Index to assess travel networks and disease transmission risk in Oceania. The results showed high connectivity between Oceania and countries in Asia, Europe, and North America, with variability in the geographical distribution of international connections among Pacific Island Countries and Territories.

BMJ OPEN (2021)

Article Immunology

mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern

Paulina Kaplonek, Stephanie Fischinger, Deniz Cizmeci, Yannic C. Bartsch, Jaewon Kang, John S. Burke, Sally A. Shin, Diana Dayal, Patrick Martin, Colin Mann, Fatima Amanat, Boris Julg, Eric J. Nilles, Elon R. Musk, Anil S. Menon, Florian Krammer, Erica Ollman Saphire, Andrea Carfi, Galit Alter

Summary: SARS-CoV-2 mRNA vaccines provide protection against COVID-19, but concerns have arisen due to the emergence of variants that may reduce the efficacy of existing vaccines. This study investigated the binding and functional capacity of antibodies from recovered individuals and those induced by the Moderna mRNA1273 COVID-19 vaccine against SARS-CoV-2 variants of concern. While neutralizing responses to the variants decreased in both groups, the Fc-mediated responses differed. Antibodies from recovered individuals showed compromised interactions with Fc receptors, while vaccine-induced antibodies maintained their ability to interact with Fc receptors and mediate antibody effector functions. These findings suggest that mRNA vaccines may offer resilience in the humoral immune response and continue to provide protection against SARS-CoV-2 variants independent of neutralization.

IMMUNITY (2022)

Article Microbiology

Serological Markers of SARS-CoV-2 Reinfection

Sameed M. Siddiqui, Kathryn A. Bowman, Alex L. Zhu, Stephanie Fischinger, Samuel Beger, Jenny S. Maron, Yannic C. Bartsch, Caroline Atyeo, Matthew J. Gorman, Ahmad Yanis, Judd F. Hultquist, Ramon Lorenzo-Redondo, Egon A. Ozer, Lacy M. Simons, Rana Talj, Danielle A. Rankin, Lindsay Chapman, Kyle Meade, Jordan Steinhart, Sean Mullane, Suzanne Siebert, Hendrik Streeck, Pardis Sabeti, Natasha Halasa, Elon R. Musk, Dan H. Barouch, Anil S. Menon, Eric J. Nilles, Douglas A. Lauffenburger, Galit Alter

Summary: As public health guidelines have relaxed, SARS-CoV-2 is likely to remain endemic due to the rise of more infectious variants. Reexposure and reinfection cases have been observed globally, highlighting the need for detecting and monitoring reinfection to prevent vaccine escape mutations. This study identifies simple immune biomarkers of reinfection in rhesus macaques and demonstrates their potential utility in human reinfection cases, providing a cost-effective and scalable marker for targeted pandemic response.
Article Biochemistry & Molecular Biology

SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort

Emilie Finch, Rachel Lowe, Stephanie Fischinger, Michael De St Aubin, Sameed M. Siddiqui, Diana Dayal, Michael A. Loesche, Justin Rhee, Samuel Beger, Yiyuan Hu, Matthew J. Gluck, Benjamin Mormann, Mohammad A. Hasdianda, Elon R. Musk, Galit Alter, Anil S. Menon, Eric J. Nillesid, Adam J. Kucharski

Summary: This study analysed longitudinal PCR and serological testing data from a cohort of US employees and found that primary infection with SARS-CoV-2 provides protection against reinfection in the majority of individuals for at least 6 months.

PLOS BIOLOGY (2022)

Article Medicine, General & Internal

Protective Behaviors Associated With Gender During the 2018-2020 Ebola Outbreak in Eastern Democratic Republic of the Congo

Phuong N. Pham, Manasi Sharma, Kennedy Kihangi Bindu, Pacifique Zikomangane, Rachel C. Nethery, Eric Nilles, Patrick Vinck

Summary: This study found gender differences in adopting preventive protective behaviors against EVD. These findings suggest that it is critical to design gender-sensitive communication and vaccination strategies, while engaging women and their community as a whole in any response to infectious disease outbreaks. Research on the potential link between gender and sociodemographics factors associated with disease risk and outcomes is needed.

JAMA NETWORK OPEN (2022)

Article Cell Biology

mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions

Paulina Kaplonek, Deniz Cizmeci, Stephanie Fischinger, Ai-Ris Collier, Todd Suscovich, Caitlyn Linde, Thomas Broge, Colin Mann, Fatima Amanat, Diana Dayal, Justin Rhee, Michael de St Aubin, Eric J. Nilles, Elon R. Musk, Anil S. Menon, Erica Ollmann Saphire, Florian Krammer, Douglas A. Lauffenburger, Dan H. Barouch, Galit Alter

Summary: The successful development of COVID-19 vaccines has led to reduced morbidity and mortality. However, the emergence of viral variants has affected the efficacy of the vaccines, showing differences between two approved mRNA platforms, BNT162b2 and mRNA-1273. Understanding the differences in immune responses induced by these vaccines is important for determining their protective immunity.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Letter Infectious Diseases

Tracking immune correlates of protection for emerging SARS-CoV-2 variants

Eric J. Nilles, Cecilia Then Paulino, Michael de St Aubin, William Duke, Petr Jarolim, Isaac Miguel Sanchez, Kristy O. Murray, Colleen L. Lau, Emily Zielinski Gutierrez, Ronald Skewes Ramm, Marietta Vasquez, Adam Kucharski

LANCET INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Using Regional Sero-Epidemiology SARS-CoV-2 Anti-S Antibodies in the Dominican Republic to Inform Targeted Public Health Response

Beatris Mario Martin, Angela Cadavid Restrepo, Helen J. Mayfield, Cecilia Then Paulino, Micheal De St Aubin, William Duke, Petr Jarolim, Emily Zielinski Gutierrez, Ronald Skewes Ramm, Devan Dumas, Salome Garnier, Marie Caroline Etienne, Farah Pena, Gabriela Abdalla, Beatriz Lopez, Lucia de la Cruz, Bernarda Henriquez, Margaret Baldwin, Benn Sartorius, Adam Kucharski, Eric James Nilles, Colleen L. Lau

Summary: This study investigated the variation in seroprevalence of SARS-CoV-2 at sub-national levels in the Dominican Republic and identified factors influencing this variation. The findings showed that receiving two doses of the COVID-19 vaccine was associated with significantly higher odds of seropositivity, indicating the importance of vaccination in increasing population immunity. These results can inform regional-level public health responses and strategies for increasing vaccination coverage.

TROPICAL MEDICINE AND INFECTIOUS DISEASE (2023)

Article Immunology

Monitoring Temporal Changes in SARS-CoV-2 Spike Antibody Levels and Variant-Specific Risk for Infection, Dominican Republic, March 2021-August 2022

Eric J. Nilles, Michael de St Aubin, Devan Dumas, William Duke, Marie Caroline Etienne, Gabriela Abdalla, Petr Jarolim, Timothy Oasan, Salome Garnier, Naomi Iihoshi, Beatriz Lopez, Lucia de la Cruz, Yosanly Cornelio Puello, Margaret Baldwin, Kathryn W. Roberts, Farah Pena, Kara Durski, Isaac Miguel Sanchez, Sarah M. Gunter, Alexander R. Kneubehl, Kristy O. Murray, Allison Lino, Sarah Strobel, Amado Alejandro Baez, Colleen L. Lau, Adam Kucharski, Emily Zielinski Gutierrez, Ronald Skewes-Ramm, Marietta Vasquez, Cecilia Then Paulino

Summary: To assess the changes in SARS-CoV-2 spike binding antibody prevalence and its implications for immunologic protection against variants of concern, a prospective study was conducted in the Dominican Republic from March 2021 to August 2022, involving 2,300 patients with undifferentiated febrile illnesses. Serum samples were tested for spike antibodies and nasopharyngeal samples were tested for acute SARS-CoV-2 infection. The study found that geometric mean spike antibody titers significantly increased over time, and higher antibody levels were associated with reduced odds of acute infection, regardless of the viral strain. The combination of serologic and virologic screening could help monitor population immunologic markers and their impact on emerging variant transmission.

EMERGING INFECTIOUS DISEASES (2023)

Article Biochemical Research Methods

Diagnostic TR-FRET assays for detection of antibodies in patient samples

Hong Yue, Radoslaw P. Nowak, Daan Overwijn, N. Connor Payne, Stephanie Fischinger, Caroline Atyeo, Evan C. Lam, Kerri St. Denis, Lauren K. Brais, Yoshinobu Konishi, Romanos Sklavenitis-Pistofidis, Lindsey R. Baden, Eric J. Nilles, Elizabeth W. Karlson, Xu G. Yu, Jonathan Z. Li, Ann E. Woolley, Irene M. Ghobrial, Jeffrey A. Meyerhardt, Alejandro B. Balazs, Gali Alter, Ralph Mazitschek, Eric S. Fischer

Summary: Serological assays play an important role in diagnosing and monitoring infectious diseases. However, current methods have limitations in terms of technology and sample types. In this study, we developed a new serological assay based on TR-FRET technology, which showed exceptional versatility, scalability, and sensitivity. It outperformed or matched existing strategies in terms of sensitivity, specificity, and precision. This assay was successfully applied to measure antibody levels against different viruses and can be extended to other antigens.

CELL REPORTS METHODS (2023)

Article Immunology

Longitudinal SARS-CoV-2 Nucleocapsid Antibody Kinetics, Seroreversion, and Implications for Seroepidemiologic Studies

Michael Loesche, Elizabeth W. Karlson, Opeyemi Talabi, Guohai Zhou, Natalie Boutin, Rachel Atchley, Gideon Loevinsohn, Jun Bai Park Chang, Mohammad A. Hasdianda, Adetoun Okenla, Elizabeth Sampson, Haley Schram, Karen Magsipoc, Kirsten Goodman, Lauren Donahue, Maureen MacGowan, Lewis A. Novack, Petr Jarolim, Lindsey R. Baden, Eric J. Nilles

Summary: The substantial seroreversion of nucleocapsid total immunoglobulin found in this study emphasizes the need to account for seroreversion in seroepidemiologic studies.

EMERGING INFECTIOUS DISEASES (2022)

Article Health Care Sciences & Services

SARS-CoV-2 seroprevalence, cumulative infections, and immunity to symptomatic infection - A multistage national household survey and modelling study, Dominican Republic, June-October 2021

Eric J. Nilles, Cecilia Then Paulino, Michael De St Aubin, Angela Cadavid Restrepo, Helen Mayfield, Devan Dumas, Emilie Finch, Salome Garnier, Marie Caroline Etienne, Louisa Iselin, William Duke, Petr Jarolim, Timothy Oasan, Jingyou Yu, Huahua Wan, Farah Pena, Naomi Iihoshi, Gabriela Abdalla, Beatriz Lopez, Lucia de la Cruz, Bernarda Henriquez, Andres Espinosa-Bode, Yosanly Cornelio Puello, Kara Durski, Margaret Baldwin, Amado Alejandro Baez, Roland C. Merchant, Dan H. Barouch, Ronald Skewes-Ramm, Emily Zielinski Gutierrez, Adam Kucharski, Colleen L. Lau

Summary: This study investigated SARS-CoV-2 infection and immunological protection in the Dominican Republic, revealing a high prevalence of cumulative infections and variations in immune protection among different subgroups. These findings are important for guiding public health interventions.

LANCET REGIONAL HEALTH-AMERICAS (2022)

Article Microbiology

Serological Markers of SARS-CoV-2 Reinfection

Sameed M. Siddiqui, Kathryn A. Bowman, Alex L. Zhu, Stephanie Fischinger, Samuel Beger, Jenny S. Maron, Yannic C. Bartsch, Caroline Atyeo, Matthew J. Gorman, Ahmad Yanis, Judd F. Hultquist, Ramon Lorenzo-Redondo, Egon A. Ozer, Lacy M. Simons, Rana Talj, Danielle A. Rankin, Lindsay Chapman, Kyle Meade, Jordan Steinhart, Sean Mullane, Suzanne Siebert, Hendrik Streeck, Pardis Sabeti, Natasha Halasa, Elon R. Musk, Dan H. Barouch, Anil S. Menon, Eric J. Nilles, Douglas A. Lauffenburger, Galit Alter

Summary: This study emphasizes the importance of detecting SARS-CoV-2 reinfection and suggests that simple antibody titers and function can serve as markers of reinfection, providing increased resolution and resilience against new outbreaks.
No Data Available